Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03627832 · ClinicalTrials.gov registry record · NA
Insomnia Treatment and Problems (the iTAP Study)
A NA study of Insomnia and Alcohol; Harmful Use, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT03627832: Completed NA study of Insomnia and Alcohol; Harmful Use, sponsored by University of Missouri-Columbia.
NCT03627832 is a NA study of Insomnia and Alcohol; Harmful Use that has completed, run by University of Missouri-Columbia. The registered enrollment target is 56 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03627832, a NA study of Insomnia and Alcohol; Harmful Use, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to evaluate the efficacy of insomnia treatment in improving insomnia symptoms and alcohol-related problems among heavy-drinking young adults.
Primary Outcome
Assessed using the Insomnia Severity Index. Scores range from 0 to 28, with higher scores indicating higher insomnia severity.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Hygiene
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBT-I)
Study Locations (1)
Missouri
- University of Missouri-Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-08-29 |
| Est. Completion | 2019-09-27 |
| Phase | NA |
What the finished NCT03627832 record still lists
NCT03627832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Sleep Hygiene is the first listed.
NCT03627832 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03627832 about?
NCT03627832 is a clinical study titled "Insomnia Treatment and Problems (the iTAP Study)". This project aims to evaluate the efficacy of insomnia treatment in improving insomnia symptoms and alcohol-related problems among heavy-drinking young adults.
What is the current status of trial NCT03627832?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2018-08-29. Estimated completion is 2019-09-27.
What conditions does trial NCT03627832 study?
This clinical trial studies the following conditions: Insomnia, Alcohol; Harmful Use.
What interventions are being tested in trial NCT03627832?
The interventions under investigation include: Sleep Hygiene (BEHAVIORAL), Cognitive Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03627832?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03627832 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03627832's enrollment target sits among peer trials
56 95th of 151 higher than 54 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI